
Rapid NGS and streamlined workflows are critical to delivering timely, actionable genomic insights in blood cancers, but access, reimbursement, and expertise gaps persist.

Luisa Campos, Global Heme Lead, Medical & Scientific Affairs at Thermo Fisher Scientific.